Navigation Links
Children's Hospital of Philadelphia and BGI announce partnership and new Joint Genome Center
Date:11/9/2011

The Children's Hospital of Philadelphia and BGI, the world's largest genomics institute, today announced they have formed a partnership, BGI@CHOP, to conduct large-scale human genome sequencing and bioinformatics analysis at a newly established, state-of-the-art Joint Genome Center at Children's Hospital. The partnership will focus on the discovery of genes underpinning rare and common pediatric diseases using next-generation sequencing. The Center became fully operational last month.

The BGI@CHOP partnership will bring together the unique strengths of two world-class institutions. BGI's capabilities and expertise in whole-genome sequencing and analysis, combined with Children's Hospital's extensive biobank and expertise in clinical phenotyping, will allow scientists and clinicians to harness the power of large, detailed data sets to improve the lives of patients and families.

"The Children's Hospital of Philadelphia has built the largest pediatric biobank in the world, and because many of these samples have been linked to clinical data using an electronic medical record, we can now follow disease processes into adulthood," said Hakon Hakonarson, M.D., Ph.D., Director of the Center for Applied Genomics at Children's Hospital. "Through our partnership with BGI, we now have a clear path forward into the genomics-based personalized medicine arena."

"We are very excited about this new partnership with BGI," said Philip Johnson, M.D., Chief Scientific Officer at The Children's Hospital of Philadelphia. "It is an ideal collaboration between two world-class institutions. The ultimate goal is to change the way we diagnose and treat diseases that affect children and families, and our work with BGI is an important first step toward that end."

"This new partnership will accelerate the discovery of genetic variants underpinning rare and common pediatric diseases by joining the forces of one of the best pediatric hospitals in the worl
'/>"/>

Contact: John Ascenzi
ascenzi@email.chop.edu
267-426-6055
Children's Hospital of Philadelphia
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Childrens Hospital LA discovers growth factor essential to epicardial cell function
2. The Childrens Hospital of Philadelphia and BGI Announce Partnership and New Joint Genome Center to Target Pediatric Diseases
3. Study: Residential washers may not kill hospital-acquired bacteria
4. Researchers at Cruces Hospital describe new syndrome of slight family intellectual disability
5. Thomas Jefferson University Hospital adopts new automated laboratory
6. Mass. Eye and Ear awarded largest NIH grant in hospital’s history
7. Childrens hospitals not equipped to handle pandemics
8. Wireless network in hospital monitors vital signs
9. UH Rainbow Babies and Childrens Hospital opens asthma studies
10. A*Star scientists discover how to combat hospital-acquired infections and life-threatening toxins
11. Research provides insight into new drug resistance in hospital microbes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Children's Hospital of Philadelphia and BGI announce partnership and new Joint Genome Center
(Date:12/15/2014)... , Dec. 12, 2014 Research and ... the addition of the "Global Facial Recognition ... http://photos.prnewswire.com/prnh/20130307/600769 ... identification of individuals. Facial recognition system measures the ... nose, jaw edges, mouth, and the distance between ...
(Date:12/11/2014)... ST. PAUL, Minn. , Dec. 10, 2014 ... in wireless physiologic monitoring, has released a new ... changing needs of preclinical toxicology researchers. M series, ... to help toxicologists collect the best possible physiologic ... studies. Adding functional endpoints to toxicology ...
(Date:12/10/2014)... -- CIE San Diego has launched an innovative trust ... that enhances care coordination among social service and care ... earned a second $1 million grant from the Alliance ... in community and; will be recognized as a "Live ... 4-6p. CIE San Diego today announced the ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3New telemetry implants expected to change how large animal toxicology studies are conducted 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
... of spinal cord injuries among senior citizens (age 70 and ... as compared with younger spinal cord injury patients, researchers at ... Center of the Delaware Valley recently reported. , As the ... 20 percent of its population will be older than age ...
... Systematic Review of the use of electronic mosquito repellents (EMRs) ... therefore say that there is no reason for recommending their ... to do more research with the devices. , Malaria is ... mosquito. Manufacturers of electronic mosquito repellents (EMRs) claim that the ...
... and zanamivir, are highly effective when given as ... the influenza virus, according to an analysis of ... Research Center, University of Michigan and University of ... the American Journal of Epidemiology. The analysis also ...
Cached Biology News:Elderly spinal cord injuries increase five-fold in 30 years, Jefferson neurosurgeons find 2Antivirals effectively curb influenza virus 2Antivirals effectively curb influenza virus 3
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... LAVAL, QC, June 4 /PRNewswire-FirstCall/ - Neptune Technologies & ... it has signed an agreement with Bayer Healthcare, LLC ... United States. , "The signing of this agreement with ... business and scientific choice to pursue the more demanding ...
... June 4 Santaris Pharma today announced that,the cancer ... by,Enzon Pharmaceuticals and Santaris Pharma A/S - was well ... treated cancer patients with,advanced malignancies. EZN-2968 is being evaluated ... which was presented at the 2009 American,Society of Clinical ...
... OPTR ) today announced that the Company will present at the following investor ... 8th Annual Needham Life Sciences Conference on Wednesday, June 10, ... New York City. , Jefferies, 3rd Annual ... the Mandarin Oriental Hotel in New York City. , ...
Cached Biology Technology:Neptune Products to be commercialized by BAYER HealthCare 2Neptune Products to be commercialized by BAYER HealthCare 3LNA-Based HIF-1 Alpha Inhibitor Shows Early Signs of Clinical Benefit 2LNA-Based HIF-1 Alpha Inhibitor Shows Early Signs of Clinical Benefit 3Optimer Pharmaceuticals to Present at June 2009 Investor Conferences 2
Human FADD Affinity Purified Polyclonal Ab...
Human VEGF R3/Flt-4 Phycoerythrin MAb (Clone 54733)...
Immunogen: Synthetic Peptide: V(22) N G H E F E I E G E G E G R(36) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Human beta IG-H3 MAb (Clone 348506) Keywords: BIGH3, betaIG-H3 Protein Family: Extracellular Matrix Molecules...
Biology Products: